Inherited thrombophilias;Trombofilias hereditárias

Medicina

Volumn 34, Issue 3-4, 2001, Pages 248-257

  Franco, Rendrik F ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDHERP   (Brazil)

Author keywords

Gene; Risk Factors; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5; HEPARIN DERIVATIVE; PROTEIN C; PROTEIN S;

BLOOD CLOTTING FACTOR DEFICIENCY; CLINICAL FEATURE; CONFERENCE PAPER; GENETIC ANALYSIS; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; INHERITANCE; PATHOGENESIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 1842479111     PISSN: 00766046     EISSN: None     Source Type: Journal    
DOI: 10.11606/issn.2176-7262.v34i3/4p248-257     Document Type: Conference Paper

References (19)

1. JORDAN FLJ & NANDORFF A. The familial tendency in thromboembolic disease. Acta Med Scand 156: 267-275, 1956.
2. ROSENDAAL FR. Venous thrombosis: a multicausal disease. Lancet 353: 1167-1173, 1999.
3. VAN HYLCKAMA VLIEGA; VAN DER LINDEN IK; BERTINA RM & ROSENDAAL FR. High levels of factor IX increase the risk of venous thrombosis. Blood 96: 3678-3682, 2000.
4. SELIGSOHN U & ZIVELIN A. Thrombophilia as a multigenic disorder. Thromb Haemost 78: 297-301, 1997.
5. ZÖLLER B; GARCIA DE FRUTOS P; HILLARP A & DAHLBÄCK B. Thrombophilia as a multigenic disease. Haematologica 84: 59-70, 1999.
6. BERTINA RM; KOELEMAN RPC; KOSTER T; ROSENDAAL FR; DIRVEN RJ; DE RONDE H; VAN DER VELDEN PA & REITSMA PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67, 1994.
7. FRANCO RF; MAFFEI FH; LOURENC̃O D; MORELLI V; THOMAZINI IA; PICCINATO CE & ZAGO MA. Factor V Arg306→Thr (factor V Cambridge) and factor V Arg306®Gly mutations in venous thrombotic disease. Br J Haematol 103: 888-890, 1998.
8. POORT SW; ROSENDAAL FR; REITSMA PH & BERTINA RM. A common genetic variation in the 3′- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88: 3698-3703, 1996.
9. FRANCO RF; TRIP MD; TEN CATE H; VAN DEN ENDEA; PRINS MH; KASTELEIN JJ & REITSMA PH. The 20210 G→A mutation in the 3′- untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 104: 50-54, 1999.
10. CATTANEO M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81: 165-176, 1999.
11. D' ANGELO A & SELHUB J. Homocysteine and thrombotic disease. Blood 90: 1-11, 1997.
12. FRANCO RF; MORELLI V; LOURENC̃O D; MAFFEI FH; TAVELLA MH; PICCINATO CE; THOMAZINI IA & ZAGO MA. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 105: 556-559, 1999.
13. FRANCO R; MAFFEI F; LOURENC̃O D; PICCINATO C; MORELLI V; THOMAZINI I & ZAGO M. The frequency of 844ins68 mutation in the cystathionine β-synthase gene is not increased in patients with venous thrombosis. Haematologica 83: 1006-1008, 1998.
14. MEIJERS DC; TEKELENBURG WL; BOUMA BN; BERTINA RM & ROSENDAAL FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342: 696-701, 2000.
15. CATTO AJ; KOHLER HP; COORE J; MANSFIELD MW; STICKLAND MH & GRANT PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 93: 906-908, 1999.
16. FRANCO RF; REITSMA PH; LOURENC̃O D; MAFFEI FH; MORELLI V; TAVELLA MH; ARAÚJO AG; PICCINATO CE & ZAGO MA. Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 81: 676-679, 1999.
17. FRANCO RF & REITSMA PH. Genetic risk factors for venous thrombosis. Hum Genet 109: 369-384, 2001.
18. FRANCO RF & ZAGO MA. The role of genetic factors in venous thrombosis. Ciênc Cult 52: 35-357, 2000.
19. FRANCO RF & REITSMA PH. Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. Br J Haematol 115: 491-506, 2001.